[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053551":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":31,"responsibleParty":76,"collaborators":78,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":84,"sex":90,"minAge":91,"maxAge":18,"enrollmentInfo":92,"targetDuration":18,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":34,"whyStopped":18,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"THRIVE Digital Health App","ACTIVE_COMPARATOR","Patients assigned to the intervention will be provided a study-issued tablet computer from which they will access the THRIVE digital health app. Study staff will give intervention patients a comprehensive tutorial and detailed instructions regarding how to use the app. Tutorial sessions may be conducted in person during a clinic appointment, via telephone, and\u002For via Zoom videoconferencing. Participants will complete the intervention modules at their desired pace over approximately 10 weeks.",[13],"Behavioral: Digital Health App",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","NO_INTERVENTION","Patients assigned to the usual care group will not receive the digital app but rather standard oncology care.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Digital Health App","access to a digital health app",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"Jennifer Temel","CONTACT","6177244000","jtemel@partners.org",[32,50,60],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"University of California Los Angeles","RECRUITING","Los Angeles","California","90024","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-118.24368,34.05223,{"lat":44,"lon":43},[47],{"name":48,"role":28,"phone":18,"phoneExt":18,"email":49},"Anne Walling","AWalling@mednet.ucla.edu",{"facility":51,"status":52,"city":35,"state":36,"zip":53,"country":38,"countryCode":39,"cosmosGeoPoint":54,"geoPoint":56,"contacts":57},"Veteran Affairs Greater Los Angeles Health Care","NOT_YET_RECRUITING","90073",{"type":41,"coordinates":55},[43,44],{"lat":44,"lon":43},[58],{"name":48,"role":28,"phone":18,"phoneExt":18,"email":59},"anne.walling@va.gov",{"facility":5,"status":34,"city":61,"state":62,"zip":63,"country":38,"countryCode":39,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Boston","Massachusetts","02114",{"type":41,"coordinates":65},[66,67],-71.05977,42.35843,{"lat":67,"lon":66},[70,74],{"name":71,"role":28,"phone":72,"phoneExt":18,"email":73},"Jennifer Temel, MD","617-724-4000","JTEMEL@mgh.harvard.edu",{"name":71,"role":75,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"type":75,"investigatorFullName":71,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Principal Investigator",[79],{"name":80,"class":81},"United States Department of Defense","FED","100053551","mobile-application-to-improve-health-related-outcomes-in-patients-with-advanced-lung-cancer-100053551",false,"NCT06427954","Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer","Randomized Trial of Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer","THRIVE","Inclusion Criteria:\n\n* Adults (greater than or equal to 18 years)\n* Diagnosed with advanced non-small cell lung cancer (NSCLC) that is not being treated with curative intent or extensive stage small cell lung cancer (SCLC) within the past 12 weeks.\n* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) = 0-2 (i.e., fully active to at least ambulatory and up and about more than 50% of waking hours).\n* Sufficient English proficiency to utilize THRIVE in English (Note: patients can complete outcome measures in Spanish if preferred).\n\nExclusion Criteria:\n\n* Significant uncontrolled psychiatric disorder (e.g., psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the ability to participate in study procedures.","ALL","18 Years",{"count":93,"type":94},250,"ESTIMATED","INTERVENTIONAL",[97],"NA","Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.",[100],"Lung Cancer",[102],"Quality of life","2026-07-09",{"date":105,"type":106},"2026-07-13","ACTUAL",{"date":108,"type":106},"2024-08-06",{"date":110,"type":94},"2027-12",{"name":5,"class":6},3]